×
Credit: PROFESSOR JOHN ZAJICEK/Science Source
Welcome to The Multiple Sclerosis Journey. Join us for a multimedia exploration of where MS treatment and research stands, what the future of care may hold, and the experiences of clinicians and patients as they collaborate on the frontlines of MS care.
The Multiple Sclerosis Journey will examine new insights on the importance of early diagnosis as well as accurate identification of the four MS phenotypes and how their recognition impacts treatment selection. Join us as we examine the importance of maintaining brain health in sustaining wellness and ability among patients with MS. Experience discussions of the role of patient and physician collaboration in sustaining continuity of care and in tailoring therapy to individual patient needs and preferences.

And, importantly, view the impact of MS through the eyes of individual patients who generously tell their stories of how they build their lives around their abilities, not their disabilities.

The road to a cure for MS lies ahead. Along the way, clinicians, physicians, and patients are sharing their stories of working toward that goal at The Multiple Sclerosis Journey. We invite you to join them.

Walk with us.

Featured Articles

Imaging MS: Emerging approaches for precision diagnosis and staging of MS

A number of emerging MRI measures with which to diagnose and stage multiple sclerosis (MS) are in development and nearly ready for expanded clinical use, according to a recent review article in the Multiple Sclerosis Journal

Consider psychological factors when assessing adherence to MS treatment

Reasons for not adhering to treatment among patients living with multiple sclerosis (MS) involve psychological factors just as much as concerns about treatment effectiveness or side effects, according to recent research published in the International Journal of MS Care.

Cognitive-behavioral therapy may help address pain and depression in patients with MS

People with multiple sclerosis (MS) who received cognitive-behavioral therapy (CBT) in addition to standard of care had better, but not significantly different, pain and depressive symptom outcomes over a period of time, compared with people who received an educational intervention, according to recent research in the International Journal of MS Care.

Virtual reality detects early impairment in walking balance

Researchers seeking simple and sensitive ways to detect walking balance impairments early on – before such impairments become clinically apparent in patients with multiple sclerosis (MS) – have reported success in the lab with the use of a virtual reality–based system that assesses one’s responses to subtle visual perturbations while walking.

MS groups weigh how DMT may influence COVID-19 risks

Disease-modifying therapies for multiple sclerosis may affect the risk of COVID-19 infection, but much information about this subject remains uncertain. Several groups have provided guidance based on scientific principles.